相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

卵巢癌的免疫疗法:以定制的免疫表型为基础的方法

Eleonora Ghisoni^1,2,3, Matteo Morotti^1,2,3, Apostolos Sarivalasis¹

¹Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Nature reviews. Clinical oncology

|September 4, 2024

概括

用免疫检查点抑制剂 (ICI) 进行的免疫疗法在卵巢癌中表现出有限的成功,原因是瘤耐药性. 未来的策略包括通过CD8+ T细胞对瘤进行分类,并将免疫疗法结合起来以获得更好的结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症研究癌症研究

背景情况:

卵巢癌细胞表达了PD-1和PD-L1.1等免疫检查点分子.
透瘤的淋巴细胞与卵巢癌的更好的存活率相关.
目前在卵巢癌中进行的免疫检查点抑制剂 (ICI) 试验取得了令人失望的结果.

研究的目的:

审查ICI试验在卵巢癌中的结果.
为卵巢癌提出基于CD8+T细胞的免疫型分类.
概述改善卵巢癌免疫疗法疗效的策略.

主要方法:

对卵巢癌中ICI的临床试验数据的审查.
对瘤免疫生物学和抵抗机制的分析.
关于免疫表型分类和组合治疗策略的建议.

主要成果:

对ICI缺乏反应与瘤异质性和瘤微环境 (TME) 有关.
临床前数据支持针对特定卵巢癌免疫类型的组合免疫疗法.
整合TME免疫表型和遗传数据可以指导量身定制的治疗.

结论:

有效的卵巢癌免疫疗法需要了解瘤免疫生物学和克服抵抗力.
基于CD8+T细胞的系统分类和组合疗法对于未来的成功至关重要.
基于组织的分析和合作研究对于推进卵巢癌免疫疗法和采用细胞疗法至关重要.

更多相关视频

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...